(PRWEB) October 07, 2013
Patheon Inc., a leading provider of contract development and manufacturing services to the global pharmaceutical industry, was awarded the CMO Leadership Award for the third consecutive year in the areas of quality, reliability, innovation and productivity.
“Every day at Patheon we are committed to providing our clients with the industry’s leading customer experience. Quality, reliability, innovation and productivity are cornerstones to our vision and it is rewarding to be recognized for the third consecutive year by our customers and the industry,” says Jim Mullen, CEO, Patheon. “It is because of our customers that we are able to improve the quality of life for patients and it is because of our employees that we help them excel.”
The CMO Leadership Awards are presented by Life Science Leader, based on research conducted by Nice Insight. The awards recognize companies ranked in the top 20 percent of their respective categories, and are based on a survey of more than 10,000 pharmaceutical and biotechnology executives.
For more information on the award, visit http://www.cmoleadershipawards.com.
Patheon Inc. (TSX: PTI) is a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry for a full array of solid and sterile dosage forms. Through the company’s recent acquisition of Banner Pharmacaps – a market leader in soft gelatin capsule technology – Patheon now also includes a proprietary products and technology business.
Patheon provides the highest quality products and services to approximately 300 of the world's leading pharmaceutical and biotechnology companies. The company's integrated network consists of 16 locations, including 13 commercial contract manufacturing facilities and 9 development centers across North America and Europe. Patheon enables customer products to be launched with confidence anywhere in the world. For more information visit http://www.patheon.com.